Multiple Sclerosis Awareness Month: A Journey of Hope and Progress
StrategyGen Co. (SBA Certified HUBZone Small Business)
REGULATORY-POLICY | COMPLIANCE | QUALITY IMPROVEMENT | DATA ANALYTICS | RESEARCH | TECHNICAL ASSISTANCE | EDUCATION
@Multiple Sclerosis Awareness Month: A Journey of Hope and Progress
March is Multiple Sclerosis (MS) Awareness Month, a time when we come together to raise awareness about this complex and often misunderstood disease. MS affects the central nervous system, impacting millions of lives worldwide. In this article, we’ll explore the significance of MS Awareness Month, delve into the statistics, and reflect on the remarkable changes that have occurred over the past two decades.
?
The MS Experience:
Living with MS is a daily challenge. It affects mobility, cognition, and emotional well-being. This year’s focus is on stories and connections—the human side of MS. Each patient’s journey is unique, but common threads bind us together. Walking difficulties, pain, fatigue, cognitive impairment, and emotional struggles are part of the MS landscape. By sharing our experiences, we create a supportive community that uplifts and educates.
?
“Multiple Sclerosis News Today has a handful of MS patients writing regularly, but they’re only a drop in the pool of voices that deserve to be heard. [This] is our opportunity to amplify those voices and provide a more diverse picture of what the patient, caregiver, and specialist community wants the world to know about life with MS.” — Brad Dell Director of Community Content, Bionews, Inc. Inc
?
A Closer Look:
Global Impact: MS affects more than 1.8 million people worldwide.
U.S. Numbers: As of 2019, nearly one million people in the United States are living with MS.
Gender Disparity: Women are two to three times more likely to develop MS than men.
Age of Onset: Most people are diagnosed between the ages of 20 and 50.
Advancements in the Past 20 Years
领英推荐
In the last two decades, significant progress has been made in understanding and managing MS:
?
Treatment Options: High-income countries now offer a range of oral, intravenous, and injectable medications for MS. These treatments help manage symptoms, slow disease progression, and improve quality of life. However, accessibility remains a challenge in low- and middle-income countries.
Research Breakthroughs: Investigating the link between the Epstein-Barr Virus (EBV) and MS has been a focus. While more research is needed, these findings offer hope for targeted therapies.
Patient Advocacy: Organizations like the Multiple Sclerosis Association of America (MSAA) tirelessly promote awareness, education, and support. Their theme this year, “Improving Lives Through Supportive Connections,” underscores the importance of social interactions in MS management.
Join the Conversation
Let’s raise our voices during MS Awareness Month! Connect with others using the hashtags:
#MSSpotlight: Share your personal MS journey and inspire others.
#MSAwareness: Spread knowledge and understanding.
#HopeForMS: Celebrate progress and advocate for change.
#MSCommunity: Connect with fellow warriors.
#EndMS: Together, we can work toward a world without MS.
Remember, every story matters. By standing together, we create a brighter future for everyone affected by MS.
wwwLessBarriers.com * Make every day easier #VeteranTrayGiveaway
6 个月If you are a man or a woman with low hormones you may want to read this research on how addressing these deficiencies can impact your disease. Good luck working with a Endocrinologist (hormone doctor) to help you. 1. Hormonal Therapies in MS: A Review of Clinical Data: This review discusses the potential effects of exogenous hormones on MS, including the use of combined oral contraceptives and estriol, which have shown modest effects on inflammatory activity and potential neuroprotective effects (1). 2. Influence of Hormones in MS: Focus on the Most Important Hormones: This article reviews the role of various hormones, including thyroid, melatonin & sex hormones, in MS pathogenesis. It highlights their immunoregulatory and neuroprotective effects(2). 3. Menopause and MS: This article from the MS Foundation explores how hormone replacement therapy is being studied to mitigate symptom exacerbation in women with MS, particularly after menopause(3). Cite 1. Hormonal Therapies in MS: a Review of Clinical Data | Current Neurology & Neuroscience Reports (springer.com) 2. Influence of hormones in MS: focus on the most important hormones | Metabolic Brain Disease (springer.com) 3. MS Foundation - Menopause & MS (msfocus.org)